Canada's Aurora Cannabis Q4 revenue beats estimates

Aurora Cannabis

11/06/2026 12:17

Overview
Canada medical cannabis producer's Q4 revenue rose 10% yr/yr, beating analyst expectations
Q4 adjusted EBITDA and adjusted net income both declined from prior year period
Company completed Safari Flower acquisition in April to expand EU-GMP manufacturing capacity

Outlook
Aurora expects fiscal 2027 total net revenue to decline, aligning with fiscal 2025 cannabis net revenue
Company sees fiscal 2027 adjusted gross margin before FV adjustments in the mid to high fifties
Aurora expects lower annual adjusted EBITDA in fiscal 2027, with quarter-to-quarter variability

Result Drivers
MEDICAL CANNABIS GROWTH - Q4 revenue increase was mainly due to 14% growth in global medical cannabis, led by higher sales in Germany, Poland, and to insured patients in Canada
MARGIN PRESSURE - Adjusted gross margin declined due to higher sales with lower margins and strategic price reductions in medical cannabis
CONSUMER CANNABIS EXIT - Consumer cannabis revenue fell as company continued winding down this segment to focus on medical markets

Company press release: ID:nPn2xsvD2a

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
C$84.82 mln
C$75.70 mln (6 Analysts)
Q4 Adjusted Net Income
 
C$5.58 mln
 
Q4 Adjusted EBITDA
 
C$9.23 mln
 
Q4 Net Income from Cont Ops
 
-C$27.60 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the pharmaceuticals peer group is "buy"
Wall Street's median 12-month price target for Aurora Cannabis Inc is C$8.00, about 74.3% above its June 10 closing price of C$4.59

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)